[removed]Bivalirudin Clinical BPCA

First Page		Document Content
Hematology Bivalirudin Direct thrombin inhibitor Pharmacometrics Clinical trial Anticoagulant Thrombin time Heparin Thrombocytopenia Pharmacology Pharmaceutical sciences Medicine		[removed]Bivalirudin Clinical BPCA Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 1,78 MB Share Document on Facebook

	warfarin isotype genetic, warfarin first affects which factor new alternative for warfarin warfarin and coagulation pathway. warfarin substitutes provac warfarin 24 mg. validated methods for warfarin sodium medical warfa DocID: 1pADC - View Document
	Pharmaceutical Management Agency Annual Review 2011 Highlights DocID: 18xrA - View Document
	Use of 4-factor prothrombin complex concentrate in the treatment of a gastrointestinal hemorrhage complicated by dabigatran DocID: 15XFC - View Document
	Treatment injury case study October 2012 – Issue 49 Sharing information to enhance patient safety Dabigatran usage DocID: 14Wt0 - View Document
	Guideline for managing patients on Dabigatran (Pradaxa®) Statewide DocID: 14V05 - View Document